# Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence

> **NCT04078399** · NA · UNKNOWN · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 30 (estimated)

## Conditions studied

- HSCT
- Efficacy and Safety

## Interventions

- **DRUG:** Azacitidine combined with interferon preemptive treatment

## Key facts

- **NCT ID:** NCT04078399
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-28
- **Primary completion:** 2022-08-28
- **Final completion:** 2022-08-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078399, "Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04078399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*